ABT – abbott laboratories (US:NASDAQ)
Stock Stats
News
MiniMed posts double-digit sales growth, widening net loss [Yahoo! Finance]
Abbott Laboratories (ABT) had its price target lowered by UBS Group AG from $158.00 to $135.00. They now have a "buy" rating on the stock.
Abbott Laboratories (ABT) had its price target lowered by Argus from $140.00 to $125.00. They now have a "buy" rating on the stock.
Abbott Laboratories (ABT) had its price target lowered by Leerink Partners from $119.00 to $106.00. They now have a "market perform" rating on the stock.
Abbott Laboratories: Buy The Dip On This Dividend King [Seeking Alpha]
Form 8-K ABBOTT LABORATORIES For: Apr 10
Form 8-K ABBOTT LABORATORIES For: Apr 16
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Stratton John G
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Roman Michael F
Form 4 ABBOTT LABORATORIES For: Mar 31 Filed by: Gonzalez Patricia Paola
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.